BBOT · BridgeBio Oncology Therapeutics, Inc.
$9.60
+0.65 (+7.26%)
At close · Aug 19
Market Cap
$717.56M
Shares
80.17M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$134.04M
-80.5%
FY2025
Diluted EPS
-$4.30
+99.9%
FY2025
Operating Cash Flow
-$113.89M
-107%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $162.15M | $121.2M | $73.11M | — | |
| $36.8M | $24.62M | $7.76M | $41.69K | |
| $198.96M | $145.82M | $80.86M | — | |
| -$198.96M | -$145.82M | -$80.86M | -$41.69K | |
| $8.86M | — | $8.45M | — | |
| $16.84M | $11.78M | $6.59M | — | |
| — | $0 | $0 | — | |
| -$182.11M | -$134.04M | -$74.28M | -$41.69K | |
| -$183.12M | -$134.38M | -$73.93M | — | |
| USD/shares | — | -$4.30 | -$5,756.41 | — |
| USD/shares | — | -$4.30 | -$5,756.41 | — |
| shares | — | 31.14M | 12.9K | — |
| shares | — | 31.14M | 12.9K | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 5.05×
EV/EBIT
—
Peer median 23.65×
P/E (TTM)
—
Peer median 13.58×
Peer medians compare against the 309 similar-size Biotechnology companies (of 546 listed).
Key facts
CIK
1869105
CUSIP
107924102
13F (30d)
66 filings
65 filers
Visit website
Investor relations